Breast cancer is the second most common cancer in the world and, by far, the most frequent cancer among women. Every 19 seconds someone is diagnosed with breast cancer and every 74 seconds someone dies from it!
Biocon reported strong Q2FY17 results. Small Molecules, Biologics and Research Services businesses showed strong growth while it was a stand-out quarter for the Biologics business.
Part 2 – The potential financial benefits and better health outcomes from biosimilars use could spur their uptake in health systems globally.
Antimicrobial resistance (AMR) represents a global catastrophe that threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.